Effect of cross-linking on physicochemical properties of chitosan mucoadhesive microspheres: A factorial approach
DOI:
https://doi.org/10.22377/ijgp.v3i1.57Abstract
The objective of the present study was to develop chitosan-based mucoadhesive microspheres of Clarithromycin, to provide a prolongedcontact time for drug delivery of antibiotics, to treat stomach ulcers. Chitosan mucoadhesive microspheres with small particle size and good sphericity were prepared by an emulsification technique using glutaraldehyde as a cross linking agent. Glutaraldehyde, the aldehyde most frequently employed as a chemical cross linker agent for proteins, was also used as a control. The prepared microspheres were optimized by 32 factorial design, using the concentration of the cross linking agent (X1) and time of cross linking (X2) with respect to their morphological aspects, percentage entrapment, in-vitro drug release and percentage mucoadhesion. Microspheres
were discrete, spherical and free flowing. The microspheres exhibited a good mucoadhesive property in the in vitro wash-off test and also showed a high percentage of drug entrapment efficiency. The best batch exhibited a high drug entrapment efficiency of 45% and percentage mucoadhesion after 5 hours was 15%. The drug release from microspheres was characterized by the initial burst effect followed by sustained release for more than 12 hours. It was concluded that drug entrapment efficiency was increased with an increase in glutaraldehyde concentration and an increase in cross linking time. As the glutaraldehyde concentration and cross linking time increased, the percentage of mucoadhesion decreased. Thus chitosan microspheres appeared to be, technically, promising mucoadhesive drug delivery systems for delivering Clarithromycin, to treat stomach ulcers.
Key words: Chitosan, clarithromycin, cross linking, factorial design, glutaraldehyde, mucoadhesive microspheres
Downloads
References
Chun M, Sah H, Choi H. Preparation of mucoadhesive
microspheres containing antimicrobial agents for eradication of
Helicobactor pylori. Int J Pharm 2005;297:172-9.
Kanamaru T, Nakano Y, Toyoda Y, Miyagawa KI, Tada M, Kaisho T,
et al. In vitro and in vivo antibacterial activities of TAK-o83, an agent
for treatment of Helicobactor pylori infection. Antimicrob Agents
Chemother 2001;45:2455-9.
Higo S, Ori K, Takeuchi H, Yamamoto H, Hino T, Kawashima Y.
A novel evaluation method of gastric mucoadhesive property
in-vitro and the mucoadhesive mechanism of tetracyclinesucralfate
acidic complex for eradication of Helicobactor pylori.
Pharm Res 2003;21:413-9.
Nagahara N, Akiyama Y, Nakao M, Tada M, Kitano M,
Ogawa Y. Mucoadhesive microspheres containing amoxicillin
for clearance of Helicobactor pylori. Antimicrob Agents Chemother
;42:2492-4.
Patel JK, Bodar MS, Patel AA. Formulation and optimization of
mucoadhesive microspheres of metoclopramide. Indian J Pharma
Sci 2004;66:300-5.
Woodley J. Bioadhesion: New possibilities for drug administration?
Clin Pharmacokinet 2001;40:77-84.
Singla AK, Sharma ML, Dhawan S. Nifedipine loaded chitosan
microspheres: Internal structure characterization. Biotech
Histochem 2001;76:165-71.
Dini E, Alexandridou S, Kiparissides C. Synthesis and
characterization of cross-linked microspheres for drug delivery
application. J Microencapsul 2003;20:375-85.
Thanoo B, Sunny MC, Jayakrishnan A. Cross linked chitosan
microspheres: Preparation and evaluation as a matrix for the
controlled release of pharmaceuticals. J Pharm Pharmacol
;44:283-6.
Orienti I, Aiedeh K, Gianasi E, Bertasi V, Zecchi V. Indomethacin
loaded chitosan microspheres correlation between the erosion
process and the release kinetics. J Microencapsul 1996;13:463-72.
Vanessa L, Gonçalves, Mauro C, Laranjeira M, Valfredo T. Effect
of crosslinking agents on chitosan microspheres in controlled
release of diclofenac sodium, polÃmeros. Ciência e Tecnologia
;15:6-12.
Lehr CM, Bouwstra JA, Tukker JJ, Junginger HE. Intestinal transit
of bioadhesive microspheres in an in situ loop in the rat. J Control
Release 1990;13:51-62.
Chowdary KP, Rao YS. Design and in vitro and in vivo evaluation
of mucoadhesive microcapsules of glipizide for oral controlled
release: A technical note. AAPS PharmSciTech 2003;4:E39.
Ugwoke MI, Verbeke N, Kinget R. Microencapsulation of
Apomorphine HCl with gelatin. Int J Pharma 1997;148:23-32.
Reddy BP, Dorle AK, Krishna DR. Albumin microsphere: Effect
of process variables on size distribution and in-vitro release. Drug
Dev Indus Pharmacy 1990;16:1791-803.
Sahin S, Selek H, Ponchel G, Ercan MT, Sargon M, Hincal AA,
et al. Preparation, characterization and in vivo distribution of
terbutaline sulfate loaded albumin microspheres. J Control Release
;82:345-58.
Raymond G, Degennaro M, Mikeal R. Preparation of gelatin
phenytoin sodium microspheres: An in vitro and in vivo evaluation.
Drug Dev Indus Pharmacy 1990;16:1025-51.
Fan H, Dash AK. Effect of cross-linking on the in vitro release
kinetics of doxorubicin from gelatin implants. Int J Pharm
;213:103-16.
Chuo W, Tsai T, Hsu S, Cham T. Preparation and in vitro
evaluation of nifedipine loaded albumin microspheres crosslinked
by different glutaraldehyde concentrations. Int J Pharma
;144:241-5.
